IoannouGN, BaraffA, FoxA, et al.Rates and factors associated with documentation of diagnostic codes for long COVID in the National Veterans Affairs Health Care System. JAMA Netw Open, 2022; 5(7):e2224359.
2.
HammelIS, TosiDM, TangF, PottH, RuizJG. Frailty as a risk factor for post-acute sequelae of COVID-19 among US veterans during the Delta and Omicron waves. J Am Geriatr Soc, 2023; 71(12):3826–3835; doi: 10.1111/jgs.18584
3.
BoweB, XieY, Al-AlyZ. Postacute sequelae of COVID-19 at 2 years. Nat Med, 2023; 29(9):2347–2357.
4.
MunipalliB, SeimL, DawsonNL, KnightD, DabrhAMA. Post-acute sequelae of COVID-19 (PASC): A meta-narrative review of pathophysiology, prevalence, and management. SN Compr Clin Med, 2022; 4(1):90.
5.
TsaiS, NguyenH, EbrahimiR, et al.COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans. Sci Rep, 2021; 11(1):8497.
6.
UpchurchDM, WongMS, YuanAH, et al.COVID-19 infection in the Veterans Health Administration: Gender-specific racial and ethnic differences. Womens Health Issues, 2022; 32(1):41–50.
7.
AhmadK, ErqouS, ShahN, et al.Association of poor housing conditions with COVID-19 incidence and mortality across US counties. PLoS One, 2020; 15(11):e0241327.
8.
MarokoAR, NashD, PavilonisBT. COVID-19 and inequity: A comparative spatial analysis of New York City and Chicago hot spots. J Urban Health, 2020; 97(4):461–470.
9.
ChenJT, KriegerN. Revealing the unequal burden of COVID-19 by income, race/ethnicity, and household crowding: US county vs ZIP code analyses. Harvard Center for Population and Development Studies Working Paper Series, Volume 19, Number 1. April 21, 2020.
10.
KimSJ, BostwickW. Social vulnerability and racial inequality in COVID-19 deaths in Chicago. Health Educ Behav, 2020; 47(4):509–513.
StephensMD, GazmararianJA, KhakhariaA. Prevalence and risk factors of post-acute sequelae of COVID-19 among United States Veterans. Ann Epidemiol, 2023; 89:1–7.
14.
GardnerJ, BrownG, Vargas-CorreaJ, WeaverF, RubinsteinI, GordonHS. An assessment of Veterans attitudes and willingness to receiving the COVID-19 vaccine: a mixed methods study. BMC Infect Dis, 2022; 22(1):308.
15.
XieY, ChoiT, Al-AlyZ. Association of treatment with nirmatrelvir and the risk of post-COVID-19 condition. JAMA Intern Med, 2023; 183(6):554–564.
16.
IoannouGN, BerryK, RajeevanN, et al.Effectiveness of nirmatrelvir-ritonavir against the development of post-COVID-19 conditions among U.S. veterans: A target trial emulation. Ann Intern Med, 2023; 176(11):1486–1497.
WanderPL, BaraffA, FoxA, et al.Rates of ICD-10 Code U09.9 documentation and clinical characteristics of VA patients with post-COVID-19 condition. JAMA Netw Open, 2023; 6(12):e2346783.
19.
SokolY, SilverC, GlattS, et al.Long COVID coping and recovery (LCCR): Developing a novel recovery-oriented treatment for veterans with long COVID. Contemp Clin Trials Commun, 2023; 36:101217.
20.
Al-AlyZ. Prevention of long COVID: Progress and challenges. Lancet Infect Dis, 2023; 23(7):776–777.